Phase I/II Study of SCTB39-1 in Advanced Solid Tumours

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 23, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG

SCTB39-1

SCTB39-1, IV

Trial Locations (1)

RECRUITING

Cancer Hospital Chinese Academy of Medical Science, Beijing

All Listed Sponsors

lead

Sinocelltech Ltd.

INDUSTRY

NCT07050641 - Phase I/II Study of SCTB39-1 in Advanced Solid Tumours | Biotech Hunter | Biotech Hunter